1,200
Participants
Start Date
September 25, 2006
Primary Completion Date
June 4, 2007
Study Completion Date
November 6, 2007
Synflorix
1 dose injected IM in the right thigh or deltoid.
Prevenar
1 dose injected IM in the right thigh or deltoid.
Infanrix hexa
1 dose injected IM in the right thigh or deltoid.
GSK Investigational Site, Lahti
GSK Investigational Site, Turku
GSK Investigational Site, Bernay
GSK Investigational Site, Pori
GSK Investigational Site, Tampere
GSK Investigational Site, Jyväskylä
GSK Investigational Site, Dax
GSK Investigational Site, Kotka
GSK Investigational Site, Essey-lès-Nancy
GSK Investigational Site, Seinäjoki
GSK Investigational Site, Kokkola
GSK Investigational Site, Kuopio
GSK Investigational Site, Paris
GSK Investigational Site, Rouen
GSK Investigational Site, Maromme
GSK Investigational Site, Le Havre
GSK Investigational Site, Draguignan
GSK Investigational Site, Oulu
GSK Investigational Site, Colombes
GSK Investigational Site, Créteil
GSK Investigational Site, Nogent-sur-Marne
GSK Investigational Site, Espoo
GSK Investigational Site, Saint-Quentin
GSK Investigational Site, Helsinki
GSK Investigational Site, Helsinki
GSK Investigational Site, Järvenpää
GSK Investigational Site, Vantaa
GSK Investigational Site, Vantaa
GSK Investigational Site, Nice
GSK Investigational Site, Bydgoszcz
GSK Investigational Site, Dębica
GSK Investigational Site, Krakow
GSK Investigational Site, Oleśnica
GSK Investigational Site, Poznan
GSK Investigational Site, Siemianowice Śląskie
Lead Sponsor
GlaxoSmithKline
INDUSTRY